Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance: response to Gunton et al
Komorowski, J.; Juturu, V.
Diabetes care 28(7): 1841-2; author reply 1842-3
2005
ISSN/ISBN: 0149-5992 PMID: 15983360 DOI: 10.2337/diacare.28.7.1841-a
Accession: 015275623
PDF emailed within 0-6 h: $19.90
Related References
Gunton, J.-E.C., N.W.; Hitchman, R.; Hams, G.; Sullivan, C.; Foster-Powell, K.; Mcelduff, A. 2005: Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile: A Randomized, Placebo-Controlled, Double-Blind Trial of Supplementation in Subjects With Impaired Glucose Tolerance: Response to Komorowski and Juturu Diabetes care 28(7): 1842-1843Gunton, J.E.; Cheung, N.Wah.; Hitchman, R.; Hams, G.; O'Sullivan, C.; Foster-Powell, K.; McElduff, A. 2005: Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance Diabetes Care 28(3): 712-713
Kennedy, L. 2006: Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile: A Randomized, Placebo-controlled, Double-blind Trial of Supplementation in Subjects With Impaired Glucose Tolerance Yearbook of Endocrinology 2006: 6-7
Ho, S.C.; Chen, Y-ming.; Ho, S.S.S.; Woo, J.L.F. 2007: Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial Menopause 14(5): 905-912
de Oliveira, A.Madruga.; Rondó, Pícia.Helen.Carvalho.; Luzia, L.Alves.; D'Abronzo, F.Homero.; Illison, V.Kristine. 2011: The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial Diabetes Research and Clinical Practice 92(2): 253-260
Hajimoosayi, F.; Jahanian Sadatmahalleh, S.; Kazemnejad, A.; Pirjani, R. 2020: Effect of ginger on the blood glucose level of women with gestational diabetes mellitus (GDM) with impaired glucose tolerance test (GTT): a randomized double-blind placebo-controlled trial Bmc Complementary Medicine and Therapies 20(1): 116
Uusitupa, M.I.; Mykkänen, L.; Siitonen, O.; Laakso, M.; Sarlund, H.; Kolehmainen, P.; Räsänen, T.; Kumpulainen, J.; Pyörälä, K. 1992: Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels British Journal of Nutrition 68(1): 209-216
Simental-Mendía, L.E.; Guerrero-Romero, F. 2019: Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind, placebo-controlled trial Nutrition 58: 7-10
Ye, Y.-B.; Chen, A.-L.; Lu, W.; Zhuo, S.-Y.; Liu, J.; Guan, J.-H.; Deng, W.-P.; Fang, S.; Li, Y.-B.; Chen, Y.-M. 2015: Daidzein and genistein fail to improve glycemic control and insulin sensitivity in Chinese women with impaired glucose regulation: a double-blind, randomized, placebo-controlled trial Molecular Nutrition and Food Research 59(2): 240-249
Polansky, M.M.; Anderson, R.A.; Bryden, N.A.; Glinsmann, W.H. 1982: Chromium and brewers yeast supplementation of human subjects effect on glucose tolerance serum glucose insulin and lipid parameters Federation Proceedings 41(3): Abstract 709
Mkrtumyan, A.; Ametov, A.; Demidova, T.; Volkova, A.; Dudinskaya, E.; Vertkin, A.; Vorobiev, S. 2022: A new Approach to Overcome Insulin Resistance in Patients with Impaired Glucose Tolerance: the Results of a Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Efficacy and Safety of Subetta Journal of Clinical Medicine 11(5)
Nabhani, Z.; Hezaveh, S.Jamal.Ghaemmaghami.; Razmpoosh, E.; Asghari-Jafarabadi, M.; Gargari, B.Pourghassem. 2018: The effects of synbiotic supplementation on insulin resistance/sensitivity, lipid profile and total antioxidant capacity in women with gestational diabetes mellitus: A randomized double blind placebo controlled clinical trial Diabetes Research and Clinical Practice 138: 149-157
Guerrero Romero, F.; Tamez Perez, H.; Gonzalez Gonzalez, G.; Salinas Martinez, A.; Montes Villarerreal, J.; Trevino Ortiz, J.; Rodriguez Moran, M. 2003: Oral Magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance A double-blind placebo-controlled randomized trial Diabetes and Metabolism 29(Hors serie 2): 4S121
Guerrero-Romero, F.; Tamez-Perez, H.E.; González-González, G.; Salinas-Martínez, A.M.; Montes-Villarreal, J.; Treviño-Ortiz, J.H.; Rodríguez-Morán, M. 2004: Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial Diabetes and Metabolism 30(3): 253-258
Bone, H.G.; Lindsay, R.; McClung, M.R.; Perez, A.T.; Raanan, M.G.; Spanheimer, R.G. 2013: Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: a randomized, double-blind, placebo-controlled study Journal of Clinical Endocrinology and Metabolism 98(12): 4691-4701
Poizot-Martin, I.; Drogoul-Vey, M.P.; Di Stefano, D.; Jouve, E.; Fabre, G.; Saout, A.; Gastaut, J.A. 2009: A randomized, double-blind, placebo-controlled study of benfluorex in HIV-infected patients with insulin resistance or impaired glucose tolerance HIV Clinical Trials 10(1): 33-40
Salehpour, A.; Shidfar, F.; Hosseinpanah, F.; Vafa, M.; Razaghi, M.; Amiri, F. 2013: Does vitamin D3 supplementation improve glucose homeostasis in overweight or obese women? A double-blind, randomized, placebo-controlled clinical trial Diabetic Medicine: a Journal of the British Diabetic Association 30(12): 1477-1481
Moreira-Lucas, T.S.; Duncan, A.M.; Rabasa-Lhoret, Rémi.; Vieth, R.; Gibbs, A.L.; Badawi, A.; Wolever, T.M.S. 2017: Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): A double-blind, randomized, placebo-controlled clinical trial Diabetes Obesity and Metabolism 19(1): 133-141
Samimi, M.; Zarezade Mehrizi, M.; Foroozanfard, F.; Akbari, H.; Jamilian, M.; Ahmadi, S.; Asemi, Z. 2017: The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial Clinical Endocrinology 86(4): 560-566
Jeong, S.; Min Cho, J.; Kwon, Y-In.; Kim, S-Chul.; Yeob Shin, D.; Ho Lee, J. 2019: Chitosan oligosaccharide (GO2KA1) improves postprandial glycemic response in subjects with impaired glucose tolerance and impaired fasting glucose and in healthy subjects: a crossover, randomized controlled trial Nutrition and Diabetes 9(1): 31